---
title: "The price of Vitamin D3 has shown a continuous upward trend"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/246515184.md"
description: "According to market sources, recently, the supply of global vitamin D3 raw materials has been restricted, exacerbating the supply-demand conflict in the market, with prices showing a continuous upward trend. The domestic largest vitamin D3 manufacturer, Garden Biopharmaceutical, has seen domestic market prices reach 660 yuan/kg, setting a new high for this year's prices"
datetime: "2025-06-28T12:11:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/246515184.md)
  - [en](https://longbridge.com/en/news/246515184.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/246515184.md)
generator: "portal-rs"
---

# The price of Vitamin D3 has shown a continuous upward trend

According to market sources, recently, the supply of global vitamin D3 raw materials has been restricted, exacerbating the supply-demand conflict, and prices have shown a continuous upward trend. This includes Garden Biopharmaceutical, the largest domestic vitamin D3 manufacturer, where the domestic market price has reached 660 yuan/kg, setting a new high for prices this year

### Related Stocks

- [300401.CN](https://longbridge.com/en/quote/300401.CN.md)

## Related News & Research

- [RUBBER-Japan futures rise on supply concerns in top producing regions](https://longbridge.com/en/news/297141554.md)
- [08:10 ETTruvant Acquires New Jersey-Based Multi-Pak Packaging, a Specialist in Vitamins, Supplements and OTC](https://longbridge.com/en/news/296912238.md)
- [AFYREN scales bio-based acid output and strengthens climate-resilient positioning](https://longbridge.com/en/news/297214424.md)
- [Juggernaut drills 20.24 meters of quartz-sulphide mineralization at Big One property in British Columbia’s Golden Triangle](https://longbridge.com/en/news/297182743.md)
- [Lytix says FDA clears Phase III trial plan for ruxotemitide plus pembrolizumab in high-risk melanoma](https://longbridge.com/en/news/297124839.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**